The new immunotherapy targets a variety of tumors, such as lung cancer, including amicrocitico lung cancer (NSCLC)

摘要

The current invention refers to cucumbers, nucleic acids and cells for immunotherapy. Specifically, the current invention is immunotherapy for cancer. In addition, the invention refers to cortitis of cytococcal lymphocyte (CTL) related to tumor.Stimulation of antitumor immune response by active pharmacological principle of cucumber as vaccine ingredient alone or in combination with other tumor related cucumbers The present invention involves more than 70 new cucumber sequences and their variants, one class of HLA molecules and two classes of HLA molecules from human tumor cells, which can be used for vaccine composition and trigger anti-tumor immune response.